A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris

BACKGROUND: Fixed combination calcipotriol 50 µg/g (Cal; as hydrate) plus betamethasone 0.5 mg/g (as dipropionate; BD) has been formulated in an innovative aerosol foam. OBJECTIVE: To assess systemic safety of Cal/BD aerosol foam. METHODS: In a multicentre, single-arm, open-label, maximal-use system...

Descripción completa

Detalles Bibliográficos
Autores principales: Taraska, Victoria, Tuppal, Raj, Olesen, Martin, Bang Pedersen, Claus, Papp, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708614/
https://www.ncbi.nlm.nih.gov/pubmed/26224733
http://dx.doi.org/10.1177/1203475415597094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708614/
https://www.ncbi.nlm.nih.gov/pubmed/26224733
http://dx.doi.org/10.1177/1203475415597094

Ejemplares similares